RxDoctor Payments Data

Niall Moreira, PA

Physician Assistant · Jamestown, NCNPI 1134601941

Payments from drug & device makers

$2,077in general payments, 2019–2025

Across 22 payments — averaging $94.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$707
  • Lilly USA, LLC$370
  • Bayer$248
  • Novo Nordisk$160
  • Corium, LLC$125
  • GSK$123
  • plus $344 from 4 others

What the payments were for

  • Food & beverage$2,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca6$707
Lilly USA, LLC3$370
Bayer3$248
Novo Nordisk4$160
Corium, LLC1$125
GSK1$123
Amgen1$122
Johnson & Johnson1$115
Merck1$86
Exact Sciences1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,077 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$18,293
Medicare patients
54
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$24,617
TrulicityDulaglutide17$22,095
EliquisApixaban13$19,334
LinzessLinaclotide18$14,265
JanuviaSitagliptin Phosphate13$12,702
OzempicSemaglutide11$10,301
SymbicortBudesonide/Formoterol Fumarate12$2,602
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$2,371
Atorvastatin Calcium176$1,935
Toprol XlMetoprolol Succinate12$1,391
Pravastatin Sodium97$1,305
Albuterol Sulfate HfaAlbuterol Sulfate39$1,278
Ketoconazole24$1,245
Amlodipine Besylate170$866
Omeprazole54$670

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$370$22,09517 claims
MerckJanuvia$86$12,70213 claims
Novo NordiskOzempic$160$10,30111 claims
AstraZenecaSymbicort$707$2,60212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Jamestown

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →